Federally Qualified Health Centers (FQHC)

As required by law, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) has released its Spring 2025 Semiannual Report to Congress, covering October 1, 2024, to [...]

Feldesman Partners Adam Falcone and Gustavo Matheus will present negotiation strategies for health care organizations to strengthen their payer-provider contracts and optimize payments during a CLE webinar sponsored by Strafford on Thursday, [...]

Feldesman Partners Susannah Vance Gopalan and Carrie Riley will present at the National Council for Mental Health Wellbeing’s NatCon25, taking place May 5–7, 2025, in Philadelphia, PA. Ms. Gopalan will speak during [...]

Feldesman Leifer LLP is excited to announce that Partners Kathryn E. Doi, Ted Waters, Adam J. Falcone, and Gabriel S. García will present multiple sessions at the California Primary Care Association’s (CPCA) [...]

Feldesman Managing Partner Ted Waters will present “Grants Management, Risk Mitigation, and Practical Responses to an Evolving Federal Landscape” at the Community Health Care Association of New York State’s (CHCANYS) annual Finance [...]

On April 15, President Trump signed an Executive Order reviving a previous directive to reduce the cost of insulin and injectable epinephrine for low income individuals. The Executive Order instructs the Secretary [...]

The U.S. Department of Health & Human Services (HHS) Office of Inspector General (OIG) recently issued a favorable advisory opinion to a health center proposing to refer individuals receiving non-medical, social, and [...]

Feldesman Partners Kathy Ghiladi and Susannah Gopalan will speak at the American Health Law Association’s Medicare and Medicaid Institute taking place March 26 - 28 in Baltimore, MD.  Ms. Gopalan will share [...]

On March 4, 2025, U.S. District Court Judge Brendan A. Hurson issued a nationwide preliminary injunction restricting the U.S. Department of Health and Human Services (HHS), the Health Resources and Services Administration [...]

Federally qualified health centers (FQHCs) and other federal grantees participating in the federal 340B drug discount statute face potentially devastating, practical effects on their ability to serve vulnerable patient populations from a [...]